Nesfatin-1 Suppresses Inflammation in Bronchopulmonary Dysplasia by Regulating HMGB-1/TLR4/p65/NLRP3 Signaling Pathway
Discov Med. 2025 May;37(196):933-945. doi: 10.24976/Discov.Med.202537196.83. ABSTRACT BACKGROUND: Bronchopulmonary dysplasia (BPD) is a common respiratory disease in premature infants. Nesfatin-1 is considered for the treatment …